Third Harmonic Bio, Inc. (THRD)
NASDAQ: THRD · Real-Time Price · USD
11.62
-0.84 (-6.74%)
Nov 20, 2024, 4:00 PM EST - Market closed
Third Harmonic Bio Market Cap
Third Harmonic Bio has a market cap or net worth of $523.58 million as of November 21, 2024. Its market cap has increased by 115.39% in one year.
Market Cap
523.58M
Enterprise Value
230.89M
1-Year Change
115.39%
Ranking
Category
Stock Price
$11.62
Market Cap Chart
Since the IPO on September 15, 2022, Third Harmonic Bio's market cap has decreased from $657.80M to $523.58M, a decrease of -20.40%. That is a compound annual growth rate of -9.92%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2024 | 523.58M | 18.25% |
| Dec 29, 2023 | 442.78M | 153.97% |
| Dec 30, 2022 | 174.34M | -73.50% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Theravance Biopharma | 482.15M |
| Zevra Therapeutics | 474.78M |
| Acelyrin | 471.03M |
| Arcturus Therapeutics Holdings | 469.15M |
| Esperion Therapeutics | 466.97M |
| UroGen Pharma | 461.13M |
| Korro Bio | 460.21M |
| MeiraGTx Holdings | 459.54M |